Middle East and Africa Digital Therapeutic (DTx) Market – Industry Trends and Forecast to 2028

  • Healthcare IT
  • Published Report
  • Feb 2021
  • MEA
  • 350 Pages
  • No of Tables: 82
  • No of Figures: 36

Middle East and Africa Digital Therapeutic (DTx) Market, By Product and Service Type (Hardware Products, Solutions/Software, Service), Application (Treatment/ Care-Related Applications, Preventive Applications), Purchase Mode (Group Purchase Organization, Individual), Sales Channel (B2B, B2C), Country (Saudi Arabia, South Africa, UAE, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Middle East and Africa Digital Therapeutic (DTx) Market Market Analysis and Insights: Middle East and Africa Digital Therapeutic (DTx) Market

The digital therapeutic (DTx) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 23.4% in the forecast period of 2021 to 2028 and is expected to reach USD 10,639.36 million by 2028. Increasing prevalence of chronic diseases like diabetes, hypertension among others as well as the rising awareness by government agencies will increase the growth of the digital therapeutic market.

Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders. They are utilized alone or mix with medications, devices or other therapies to optimize patient care and health outcomes. Rising remote access to therapies that are clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment.

The technological advancement which the companies make in order to grow their product line and gain profits are one of the drivers for the growth of the digital therapeutic (DTx) market. The privacy concerns related to digital therapeutic (DTx) apps may act as a restraint for the growth of the digital therapeutic (DTx) market. The collaboration between the companies will help in the growth of the market and will act as an opportunity for the digital therapeutic (DTx) market. The quality of digital therapeutic (DTx) is to be maintained in order to provide better treatment and proper care for the customers, hence, this needs to be done correctly, therefore this would act as challenge for the digital therapeutic (DTx) market because many a times the need is not met.

The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Digital Therapeutic (DTx) Market Middle East and Africa Digital Therapeutic (DTx) Market Scope and Market Size

The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since with the pandemic situation going on the safety is the prime responsibility, therefore people would tend to prefer this segment and the prevailing diseases will increase the market.
  • On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since this would provide treatment for the chronic disorders which are highly prevailing and the improved life style will tend to increase the market.
  • On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and want to get treated without any contact and the initiatives taken by the government agencies will tend to increase the market.
  • On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers and hence increase the life style and let the market grow.

Digital Therapeutic (DTx) Market Country Level Analysis

The digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.

The countries covered in the digital therapeutic (DTx) market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt, and Rest of Middle East and Africa.

Middle East and Africa is expected to grow with the substantial growth rate in the forecast period of 2021 to 2028 as Middle East and Africa counties are major developing countries and focus on increasing usage of digital therapeutic (DTx) product and rising awareness about it. South Africa is expected to dominate in the market in the Middle East and Africa market due to increasing number of cases in diabetes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by manufactures is Creating New Opportunities for Players in the Digital Therapeutic (DTx) Market

The digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Digital Therapeutic (DTx) Market Share Analysis

The digital therapeutic (DTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to digital therapeutic (DTx) market.

The major companies providing digital therapeutic (DTx) are Fitbit, Inc., ResMed, Omada Health, Inc., and Samsung among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the digital therapeutic (DTx) market.

For instance,

  • In October 2020, TrialCard’s MANGO HEALTH announced a new interoperable technology platform and launched version 2.0 of Mango Health. This latest version includes third-party health service providers with turnkey access to Mango’s robust suite of patient support modules. The company will gain more new subscribers.
  • In May 2019, CogniFit had done a study in which it had studied a general assessment that would provide adaptive learning using EEG. It would also help in the stimulation of brain areas of each cognitive skill. This helped the company to be a world leader in brain training and new technologies.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the digital therapeutic (DTx) market which also provides the benefit for organization to improve their offering for digital therapeutic (DTx).

Customization Available: Middle East and Africa Digital Therapeutic (DTx) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))

TABLE 4 MIDDLE EAST & AFRICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 33 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 SAUDI ARABIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 SAUDI ARABIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 37 SAUDI ARABIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 38 SAUDI ARABIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 39 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 SAUDI ARABIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 SAUDI ARABIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 42 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 43 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 SOUTH AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 SOUTH AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 47 SOUTH AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 48 SOUTH AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 49 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 50 SOUTH AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 SOUTH AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 53 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 UAE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 UAE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 57 UAE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 58 UAE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 59 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 UAE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 UAE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 63 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 64 ISRAEL TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 ISRAEL PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 67 ISRAEL GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 68 ISRAEL INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 69 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 70 ISRAEL B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 ISRAEL B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 73 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 74 EGYPT TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 EGYPT PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 77 EGYPT GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 78 EGYPT INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 79 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 EGYPT B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 EGYPT B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 REST OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions